Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
World News | John Lauerman and Angelica LaVito, Bloomberg | Thursday November 26, 2020
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
World News | John Lauerman and Angelica LaVito, Bloomberg | Thursday November 26, 2020
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
................................ Advertisement ................................
................................ Advertisement ................................
